Biocept Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 46.56. In total, the insiders bought 5 997 352 and sold 1 605 BIOC shares in the last 100 trades.

Insider Power

(Last 100 transactions)
46.56
Buy 5 997 352 Shares
Sell 1 605 Shares

Historical Insider Trades

Date Type Action Person Amount
Jun 16, 2023 Employee Stock option (right to buy) Buy Walsh Robert 806
Nov 17, 2022 Employee Stock Option (right to buy) Buy Dao-haddock Quyen Thi 10 000
Nov 17, 2022 Buy Dao-haddock Quyen Thi 0
Nov 17, 2022 Buy Dao-haddock Quyen Thi 0
Jul 08, 2022 Employee Stock Option (right to buy) Buy Chandler Marsha Alpert 10 000
Jul 08, 2022 Employee Stock Option (right to buy) Buy Chandler Marsha Alpert 10 000
Jul 08, 2022 Employee Stock Option (right to buy) Buy Rubinstein Linda M 10 000
Jul 08, 2022 Employee Stock Option (right to buy) Buy Gerhardt Bruce 10 000
Jul 08, 2022 Employee Stock Option (right to buy) Buy Royston Ivor 10 000
Jul 08, 2022 Employee Stock Option (right to buy) Buy Royston Ivor 10 000
Jul 08, 2022 Employee Stock Option (right to buy) Buy Wilson Margaret Faye 10 000
Mar 31, 2022 Stock Option (right to buy) Buy Taylor Darrell 15 450
Mar 31, 2022 Stock Option (right to buy) Buy Marchand Philippe 150 000
Mar 08, 2022 Buy Marchand Philippe 0
Feb 28, 2022 Stock Option (right to buy) Buy Taylor Darrell 134 550
Feb 28, 2022 Stock Option (right to buy) Buy Riccitelli Samuel D 250 000
Feb 28, 2022 Stock Option (right to buy) Buy Morales Antonino 150 000
Feb 14, 2022 Buy Taylor Darrell 0
Dec 09, 2021 Common Stock Sell Hale David F 363
Dec 09, 2021 Common Stock Sell Hale David F 71
Dec 09, 2021 Common Stock Sell Hale David F 11
Sep 02, 2021 Employee Stock Option (right to buy) Buy Nall Michael W. 100 000
Sep 02, 2021 Performance-Based Employee Stock Option (right to buy) Buy Nall Michael W. 80 000
Aug 31, 2021 Employee Stock Option (right to buy) Buy Terry Michael J 35 000
Aug 31, 2021 Employee Stock Option (right to buy) Buy Dugan Michael C 150 000
Click to get the best stock tips daily for free!

About Biocept

Biocept Biocept, Inc., a molecular oncology diagnostics company, develops and commercializes proprietary circulating tumor cell and circulating cell-free tumor DNA and RNA assays utilizing a standard blood sample. Its cancer assays provide information to healthcare providers to identify oncogenic alterations that qualify a subset of cancer patients for targeted therapy at diagnosis, progression, and monitoring to identify resistance mechanisms. The compa... BIOC Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT